Allarity Therapeutics, Inc. (ALLR) compared with its closest peers (AYTU, CLRB, TXMD, ABVC, MRKR). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Aytu BioPharma, Inc. (AYTU) | $25.12M | -1.0 |
| Cellectar Biosciences, Inc. (CLRB) | $24.39M | -0.3 |
| TherapeuticsMD, Inc. (TXMD) | $23.79M | 47.9 |
| ABVC BioPharma, Inc. (ABVC) | $23.38M | -5.4 |
| Marker Therapeutics, Inc. (MRKR) | $23.09M | -1.8 |
| Biofrontera Inc. (BFRI) | $21.91M | -0.7 |
| Cocrystal Pharma, Inc. (COCP) | $21.86M | -1.2 |
| Neuphoria Therapeutics Inc. (NEUP) | $21.35M | 7.9 |
| Celularity Inc. (CELU) | $20.29M | -0.3 |
| Tempest Therapeutics, Inc. (TPST) | $17.10M | -0.4 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
ALLR overview · ALLR earnings · ALLR financials · ALLR KPIs · ALLR investor relations · ALLR ownership · ALLR filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.